使用全血γ-干扰素释放试验（QuantiFERON SARS-CoV-2检测法）测量的新冠病毒疫苗诱导的T细胞介导免疫反应的持久性。 - Suppr

Suppr

超能文献

Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay.

作者信息

Stieber F, Allen N, Carpenter K, Hu P, Alagna R, Rao S, Manissero D, Howard J, Nikolayevskyy V

机构信息

QIAGEN Sciences Inc, 19300 Germantown Road, Germantown, MD 20874, USA.

出版信息

Pulmonology. 2023 Mar-Apr;29(2):151-153. doi: 10.1016/j.pulmoe.2022.09.006. Epub 2022 Nov 16.

DOI:10.1016/j.pulmoe.2022.09.006

PMID:36402704

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9671490/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4505/9671490/262fcab94c14/gr1_lrg.jpg

相似文献

Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay.

Pulmonology. 2023 Mar-Apr;29(2):151-153. doi: 10.1016/j.pulmoe.2022.09.006. Epub 2022 Nov 16.

T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.

J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.

Nature. 2022 Jan;601(7894):617-622. doi: 10.1038/s41586-021-04232-5. Epub 2021 Nov 23.

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.

J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004953.

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.

Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.

Geroscience. 2021 Oct;43(5):2321-2331. doi: 10.1007/s11357-021-00471-6. Epub 2021 Oct 11.

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.

Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.

Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.

J Infect Dis. 2023 Mar 1;227(5):641-650. doi: 10.1093/infdis/jiac449.

Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.

Vaccine. 2022 Jul 30;40(32):4296-4300. doi: 10.1016/j.vaccine.2022.06.052. Epub 2022 Jun 24.

Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.

Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.

引用本文的文献

QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis.

Immunol Res. 2024 Dec 27;73(1):25. doi: 10.1007/s12026-024-09570-w.

The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.

Hum Vaccin Immunother. 2024 Dec 31;20(1):2395679. doi: 10.1080/21645515.2024.2395679. Epub 2024 Aug 29.

New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.

Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.

Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set.

Viruses. 2023 May 17;15(5):1179. doi: 10.3390/v15051179.

Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity.

Diagn Microbiol Infect Dis. 2023 Jul;106(3):115948. doi: 10.1016/j.diagmicrobio.2023.115948. Epub 2023 Mar 30.

Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination.

Vaccines (Basel). 2023 Feb 10;11(2):413. doi: 10.3390/vaccines11020413.

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly.

Vaccines (Basel). 2023 Jan 18;11(2):213. doi: 10.3390/vaccines11020213.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay.

作者信息

Stieber F, Allen N, Carpenter K, Hu P, Alagna R, Rao S, Manissero D, Howard J, Nikolayevskyy V

机构信息

QIAGEN Sciences Inc, 19300 Germantown Road, Germantown, MD 20874, USA.

出版信息

Pulmonology. 2023 Mar-Apr;29(2):151-153. doi: 10.1016/j.pulmoe.2022.09.006. Epub 2022 Nov 16.

DOI:10.1016/j.pulmoe.2022.09.006

PMID:36402704

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9671490/

Abstract

摘要

相似文献

Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay.

Pulmonology. 2023 Mar-Apr;29(2):151-153. doi: 10.1016/j.pulmoe.2022.09.006. Epub 2022 Nov 16.

T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.

J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.

Nature. 2022 Jan;601(7894):617-622. doi: 10.1038/s41586-021-04232-5. Epub 2021 Nov 23.

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.

J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004953.

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.

Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.

Geroscience. 2021 Oct;43(5):2321-2331. doi: 10.1007/s11357-021-00471-6. Epub 2021 Oct 11.

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.

Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.

Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.

J Infect Dis. 2023 Mar 1;227(5):641-650. doi: 10.1093/infdis/jiac449.

Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.

Vaccine. 2022 Jul 30;40(32):4296-4300. doi: 10.1016/j.vaccine.2022.06.052. Epub 2022 Jun 24.

Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.

引用本文的文献

QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis.

Immunol Res. 2024 Dec 27;73(1):25. doi: 10.1007/s12026-024-09570-w.

The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.

Hum Vaccin Immunother. 2024 Dec 31;20(1):2395679. doi: 10.1080/21645515.2024.2395679. Epub 2024 Aug 29.

New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.

Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.

Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set.

Viruses. 2023 May 17;15(5):1179. doi: 10.3390/v15051179.

Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity.

Diagn Microbiol Infect Dis. 2023 Jul;106(3):115948. doi: 10.1016/j.diagmicrobio.2023.115948. Epub 2023 Mar 30.

Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination.

Vaccines (Basel). 2023 Feb 10;11(2):413. doi: 10.3390/vaccines11020413.

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly.

Vaccines (Basel). 2023 Jan 18;11(2):213. doi: 10.3390/vaccines11020213.